Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma

Journal of Investigative Dermatology

Volumn 108, Issue 5, 1997, Pages 743-747

  Asadullah, Khusru ^a   Friedrich, Markus ^a   Döcke, Wolf Dietrich ^a   Jahn, Sigbert ^a   Volk, Hans Dieter ^a   Sterry, Wolfram ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

CTCL; CTL; mycosis fungoides; NK cells; T cell activation

Indexed keywords

CD8 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; NATURAL KILLER CELL; PRIORITY JOURNAL; PSORIASIS; T CELL LYMPHOMA;

EID: 0030896043     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12292129     Document Type: Article

References (24)

1. Asadullah K, Döcke WD, Haeußler A, Sterry W, Volk HD: Progression of Mycosis fungoides is associated with increasing cutaneous expression of IL-10 mRNA. J Invest Dermatol 107:833-837, 1996
2. Beljaards RC, Kaudewitz P, Berti E, Gianotti R, Neumann C, Rosso R, Paulli M, Meijer CJ, Willemze R: Primary cutaneous CD30-positive large cell lymphoma with a favorable prognosis. An European multicenter study on 47 cases. Cancer 71:2097-2104, 1993
3. Bunn PA, Huberman MS, Whang-Peng J, Schechter GP, Guccion JG, Matthews MJ, Gazdar AF, Dunnick NR, Fischmann AB, Ihde DC, Cohen MH, Fossieck B, Minna JD: Prospective staging evaluation of patients with cutaneous T cell lymphomas: demonstration of a high frequency of a extracutaneous dissemination. Ann Intern Med 93:223-230, 1980
4. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (1L-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down regulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991
5. Döcke WD, Reinke P, Staffa G, Settmacher U, Höger T, Groth J, Lang K, Lock KU, Prösch S, Kimmel V, Warnke H, von Baehr R, Volk HD: An immune monitoring program for the management of immunosuppressive therapy in the early phase after transplantation. Transplantationsmedizin 1:13-28, 1994
6. Dommann SNW, Dommann-Scherrer CC, Dours-Zimmermann DR, Kural-Serbes B, Burg G: Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Arch Dermatol Res 288:163-167, 1996
7. Dummer R, Kohl O, Gillessen J, Kagi M, Burg G: Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol 129:433-436, 1993
8. Edelson RL: Cutaneus T cell lymphoma: mycosis fungoides, Sezary syndrome, and other variants. J Am Acad Dermatol 2:89-106, 1980
9. Gilmore SJ, Benson EM, Kelly JW: T-cell subsets with naive phenotype are selectively decreased in the peripheral blood of patients with mycosis fungoides. J Invest Dermatol 96:50-56, 1991
10. Greenberg PD: Mechanisms of tumor immunology. In: Stites DP, Terr A, Parslow TG (eds.). Basic and Clinical Immunology. Appleton and Lange, East Norwalk, CT, 1994, pp 569-577
11. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS: CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 32:448-453, 1995
12. Kantor AF, Curtis RE, Vonderheid EC, van Scott EJ, Fraumeni JF Jr: Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 63:1612-1615, 1989
13. Kerl K and Sterry W: Classification and staging. In: Burg G, Sterry W, (eds.) EORTC/BMFT Cutaneous Lymphoma Project Group: Recommendations for Staging and Therapy of Cutaneous Lymphomas. European Organization for Research in Treatment of Cancer, Brussels, Belgium, pp 1-10, 1987
14. Kern F, Ode-Hakim S, Nugel H, Volk HD, Reinke P: CD3+/LFA-1 "84bright" T cells represent memory-type effector cells, which during immune activation in kidney graft recipients, are marked by increased cytokine mRNA levels. Transplant Proc 27:896-899, 1996
15. Kim YH, Jensen RA, Watanabe GL, Varghese A, Hoppe RT: Clinical stage Ia (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Arch Dermatol 132:1309-1313, 1996
16. Kos FJ, Engleman EG: Immune regulation: a critical link between NK cells and CTL. Immunol Today 17:174-176, 1996
17. Lorincz AL: Cutaneous T-cell lymphoma (mycosis fungoides). Lancet 347:871-876, 1996
18. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R: Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371-2376, 1994
19. Osanto S, Jansen R, Naipal AM, Gratama JW, van Leeuwen A, Cleton FJ: In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma. Int J Cancer 43:1001-1006, 1989
20. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LW: Control of lymphocyte recirculation in man. J Immunol 150:1122-1136, 1993
21. Prinz B, Behrens W, Hölzle E, Plewig G: Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma - the Düsseldorf and Munich experience. Arch Dermatol Res 287:621-626, 1995
22. Rammensee HG, Kroschewski R, Frangoulis B: Clonal anergy induced in mature Vβ6+ T lymphocytes on immunizing Mis-1b mice with Mis-1a expressing cells. Nature 339:541-544, 1989
23. Santamaria Babi LF, Moser R, Perez-Soler MT, Picker LJ, Blaser K, Hauser C: Migration of skin-homing T-cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 154:1543-1550, 1995
24. Sowden JM, Powell RJ, Allen BR: Selective activation of circulating CD4+ lymphocytes in severe adult atopic dermatitis. Br J Dermatol 127:228-232, 1992